Deepecho

DeepEcho is a healthtech company building AI-powered fetal ultrasound analysis software to improve prenatal care and reduce infant and maternal mortality. Founded by AI scientists and physicians, DeepEcho uses deep learning algorithms to automate fetal measurements, assist with computer-aided diagnosis, and enable teleguidance for remote diagnosis — enabling screenings that are 3 to 5 times faster with greater than 95% accuracy. The platform is hardware-agnostic and mobile-compatible, designed for deployment in low-resource settings. DeepEcho received FDA 510(k) clearance in 2025 and has been backed by the Bill & Melinda Gates Foundation I3 Program and the European Bank for Reconstruction and Development.